nach oben

Abdominal Radiology

Erschienen in:

06.05.2019 | Special Section: Rectal Cancer

Current controversy, confusion, and imprecision in the use and interpretation of rectal MRI

verfasst von: Marc J. Gollub, Chandana Lall, Neeraj Lalwani, Michael H. Rosenthal

Erschienen in: Abdominal Radiology | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

There has been a rapid increase in the utilization of MRI in rectal cancer staging in the USA essentially replacing endorectal ultrasound and mimicking the trend in Europe seen in the 1990s and 2000s. Accompanying this trend, there is a demand, and recognized need, for greater precision and clarification of confusing, misunderstood and poorly understood concepts, facts, statements and nomenclature regarding rectal cancer and the use of pelvic MRI for diagnosis. As such, this Review, part evidence-based and part expert opinion, will attempt to elucidate and clarify several concepts the authors have encountered in 25 years of imaging rectal cancer, focusing on MRI.

Siegel, R.L., et al., Colorectal Cancer Incidence Patterns in the United States, 1974-2013. J Natl Cancer Inst, 2017. 109(8).

Glimelius, B., et al., Mesorectal fascia instead of circumferential resection margin in preoperative staging of rectal cancer. J Clin Oncol, 2011. 29(16): p. 2142-3.CrossRefPubMed

Orsini, R.G., et al., The modern anatomical surgical approach to localised rectal cancer. EJC Suppl, 2013. 11(2): p. 60-71.CrossRefPubMedPubMedCentral

Nougaret, S., et al., The use of MR imaging in treatment planning for patients with rectal carcinoma: have you checked the "DISTANCE"? Radiology, 2013. 268(2): p. 330-44.CrossRefPubMed

Horvat, N., I. Petkovska, and M.J. Gollub, MR Imaging of Rectal Cancer. Radiol Clin North Am, 2018. 56(5): p. 751-774.CrossRefPubMed

Quirke, P., et al., Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet, 1986. 2(8514): p. 996-9.

Group, M.S., Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology, 2007. 243(1): p. 132-9.CrossRef

Glimelius, L.B.B., The ‘good’, the ‘bad’, and the ‘ugly’ rectal cancers. Acta Oncologica, 2008. 47( 1): p.5-8.CrossRefPubMed

Nagtegaal, I.D., et al., Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol, 2002. 26(3): p. 350-7.CrossRefPubMed

10.

Birbeck, K.F., et al., Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg, 2002. 235(4): p. 449-57.CrossRefPubMedPubMedCentral

11.

Shihab, O.C., et al., Magnetic resonance imaging-detected lymph nodes close to the mesorectal fascia are rarely a cause of margin involvement after total mesorectal excision. Br J Surg, 2010. 97(9): p. 1431-6.CrossRefPubMed

12.

Stedman, T.L., Stedman’s medical dictionary, 28th edn. 2006, Philadelphia: Lippincott Williams & Wilkins

13.

Netter, F.H., Atlas of human anatomy. Sixth edition. ed. 2014, Philadelphia, PA: Saunders/Elsevier.

14.

Chung, E., et al., Accuracy of pelvic MRI in measuring tumor height in rectal cancer patients with or without preoperative chemoradiotherapy. Eur J Surg Oncol, 2018.

15.

Dujovny, N., R.M. Quiros, and T.J. Saclarides, Anorectal anatomy and embryology. Surg Oncol Clin N Am, 2004. 13(2): p. 277-93.CrossRefPubMed

16.

Nigro, N.D., et al., Combined therapy for cancer of the anal canal. Dis Colon Rectum, 1981. 24(2): p. 73-5.CrossRefPubMed

17.

Shihab, O.C., et al., Can a novel MRI staging system for low rectal cancer aid surgical planning?ω Dis Colon Rectum, 2011. 54(10): p. 1260-4.CrossRefPubMed

18.

Bamba, Y., M. Itabashi, and S. Kameoka, Preoperative evaluation of the depth of anal canal invasion in very low rectal cancer by magnetic resonance imaging and surgical indications for intersphincteric resection. Surg Today, 2012. 42(4): p. 328-33.CrossRefPubMed

19.

Scala, D., et al., Laparoscopic intersphincteric resection: indications and results. Updates Surg, 2016. 68(1): p. 85-91.CrossRefPubMed

20.

Kim, J.H., et al., High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size? Eur J Radiol, 2004. 52(1): p. 78-83.CrossRefPubMed

21.

Brown, G., et al., Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology, 2003. 227(2): p. 371-7.CrossRefPubMed

22.

Fujita, S., et al., Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial. Ann Surg, 2017. 266(2): p. 201-207.CrossRefPubMed

23.

Ogura, A., et al., Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer. J Clin Oncol, 2018: p. JCO1800032.

24.

Blazic I, P.S., Konishi T, Campbell N, Garcia-Aguilar J, Gollub MJ., Clinical Impact of Lateral Lymph Nodes at Pelvic MRI in Patients with Rectal Cancer. ECR2019 Accepted abstract, 2018.

25.

Oh, H.K., et al., Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study. Ann Surg Oncol, 2014. 21(7): p. 2280-7.CrossRefPubMed

26.

Chand, M., et al., Mucinous carcinoma of the rectum: a distinct clinicopathological entity. Tech Coloproctol, 2014. 18(4): p. 335-44.CrossRefPubMed

27.

Hugen, N., et al., Modern Treatment of Rectal Cancer Closes the Gap Between Common Adenocarcinoma and Mucinous Carcinoma. Ann Surg Oncol, 2015. 22(8): p. 2669-76.CrossRefPubMed

28.

Oberholzer, K., et al., Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation. Int J Radiat Oncol Biol Phys, 2012. 82(2): p. 842-8.CrossRefPubMed

29.

Yu, S.K., et al., Magnetic resonance imaging defined mucinous rectal carcinoma is an independent imaging biomarker for poor prognosis and poor response to preoperative chemoradiotherapy. Eur J Cancer, 2014. 50(5): p. 920-7.CrossRefPubMed

30.

Beets-Tan, R.G.H., et al., Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol, 2017.

31.

Gollub, M.J., et al., Use of magnetic resonance imaging in rectal cancer patients: Society of Abdominal Radiology (SAR) rectal cancer disease-focused panel (DFP) recommendations 2017. Abdom Radiol (NY), 2018.

32.

Barbaro, B., et al., The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease. Br J Radiol, 2017. 90(1069): p. 20150836.CrossRefPubMed

33.

Kim, M.J., et al., Accuracy in differentiation of mucinous and nonmucinous rectal carcinoma on MR imaging. J Comput Assist Tomogr, 2003. 27(1): p. 48-55.CrossRefPubMed

34.

Beets, G.L., et al., A new paradigm for rectal cancer: Organ preservation: Introducing the International Watch & Wait Database (IWWD). Eur J Surg Oncol, 2015. 41(12): p. 1562-4.CrossRefPubMed

35.

Habr-Gama, A., et al., Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control. Int J Radiat Oncol Biol Phys, 2014. 88(4): p. 822-8.CrossRefPubMed

36.

Habr-Gama, A., et al., Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg, 2004. 240(4): p. 711-7; discussion 717-8.

37.

van der Valk, M.J.M., et al., Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet, 2018. 391(10139): p. 2537-2545.CrossRefPubMed

38.

Smith, J.J., et al., Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy. JAMA Oncology, 2019. https://doi.org/10.1001/jamaoncol.2018.5896.CrossRefPubMedPubMedCentral

39.

Slater, A., et al., Distance between the rectal wall and mesorectal fascia measured by MRI: Effect of rectal distension and implications for preoperative prediction of a tumour-free circumferential resection margin. Clin Radiol, 2006. 61(1): p. 65-70.CrossRefPubMed

40.

Ye, F., et al., JOURNAL CLUB: Preoperative MRI Evaluation of Primary Rectal Cancer: Intrasubject Comparison With and Without Rectal Distention. AJR Am J Roentgenol, 2016. 207(1): p. 32-9.CrossRefPubMed

41.

Stijns, R.C., et al., The influence of endorectal filling on rectal cancer staging with MRI. Br J Radiol, 2018. 91(1089): p. 20180205.CrossRefPubMed

42.

Schrag, D., et al., Challenges and solutions in the design and execution of the PROSPECT Phase II/III neoadjuvant rectal cancer trial (NCCTG N1048/Alliance). Clin Trials, 2019: p. 1740774518824539.

43.

Vliegen, R.F., et al., Rectal cancer: MR imaging in local staging--is gadolinium-based contrast material helpful? Radiology, 2005. 234(1): p. 179-88.CrossRefPubMed

44.

Corines, M.J., et al., Gadolinium-Based Contrast Agent During Pelvic MRI: Contribution to Patient Management in Rectal Cancer. Dis Colon Rectum, 2018. 61(2): p. 193-201.CrossRefPubMedPubMedCentral

45.

Gollub, M.J., et al., Does gadolinium-based contrast material improve diagnostic accuracy of local invasion in rectal cancer MRI? A multireader study. AJR Am J Roentgenol, 2015. 204(2): p. W160-7.CrossRefPubMedPubMedCentral

46.

Gollub, M.J., et al., Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer. Eur Radiol, 2012. 22(4): p. 821-31.CrossRefPubMed

47.

Gollub, M.J., et al., Limited accuracy of DCE-MRI in identification of pathological complete responders after chemoradiotherapy treatment for rectal cancer. Eur Radiol, 2017. 27(4): p. 1605-1612.CrossRefPubMed

48.

Gollub, M.J., et al., Value of adding dynamic contrast-enhanced MRI visual assessment to conventional MRI and clinical assessment in the diagnosis of complete tumour response to chemoradiotherapy for rectal cancer. Eur Radiol, 2018.

49.

Gollub, M.J., et al., Prognostic aspects of DCE-MRI in recurrent rectal cancer. Eur Radiol, 2013. 23(12): p. 3336-44.CrossRefPubMed

50.

Dijkhoff, R.A.P., et al., Value of DCE-MRI for staging and response evaluation in rectal cancer: A systematic review. Eur J Radiol, 2017. 95: p. 155-168.CrossRefPubMed

51.

Mandard, A.M., et al., Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer, 1994. 73(11): p. 2680-6.PubMed

52.

Dworak, O., L. Keilholz, and A. Hoffmann, Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis, 1997. 12(1): p. 19-23.CrossRefPubMed

53.

Rodel, C., et al., Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol, 2005. 23(34): p. 8688-96.CrossRefPubMed

54.

Lee, S.A., et al., Impact of the new AJCC staging system and adjuvant treatment in rectal cancer. Cancer Res Treat, 2004. 36(2): p. 121-7.CrossRefPubMedPubMedCentral

55.

Trakarnsanga, A., et al., Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment. J Natl Cancer Inst, 2014. 106(10).

56.

Patel, U.B., et al., Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol, 2011. 29(28): p. 3753-60.CrossRefPubMed

57.

Sclafani, F., et al., Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer. Br J Cancer, 2017. 117(10): p. 1478-1485.CrossRefPubMedPubMedCentral

58.

Patel, U.B., et al., Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer. Ann Surg Oncol, 2012. 19(9): p. 2842-52.CrossRefPubMed

59.

Battersby, N.J., et al., A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial. Trials, 2017. 18(1): p. 394.CrossRefPubMedPubMedCentral

60.

van der Paardt, M.P., et al., Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis. Radiology, 2013. 269(1): p. 101-12.CrossRefPubMed

61.

Maas, M., et al., Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment. Ann Surg Oncol, 2015. 22(12): p. 3873-80.CrossRefPubMedPubMedCentral

62.

Gollub, M., Pelvic MRI after Induction Chemotherapy and Before Long-Course Chemoradiation Therapy for Rectal Cancer: What are the Imaging Findings? European Radiology, 2019.

63.

Sakuyama, N., et al., Histological differences between preoperative chemoradiotherapy and chemotherapy for rectal cancer: a clinicopathological study. Pathol Int, 2016. 66(5): p. 273-80.CrossRefPubMed

Titel: Current controversy, confusion, and imprecision in the use and interpretation of rectal MRI
verfasst von: Marc J. Gollub
Chandana Lall
Neeraj Lalwani
Michael H. Rosenthal
Publikationsdatum: 06.05.2019
Verlag: Springer US
Erschienen in: Abdominal Radiology / Ausgabe 11/2019
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-019-01996-3

Neu im Fachgebiet Radiologie

23.04.2024 | Pankreaskarzinom | Nachrichten

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Current controversy, confusion, and imprecision in the use and interpretation of rectal MRI

Abstract

Neu im Fachgebiet Radiologie

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Update Radiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2019

Rectal cancer lexicon: consensus statement from the society of abdominal radiology rectal & anal cancer disease-focused panel

Pathologist’s perspective on primary rectal cancer

Prediction of efficacy of neoadjuvant chemoradiotherapy for rectal cancer: the value of texture analysis of magnetic resonance images

The use of PET/MRI for imaging rectal cancer

Diffusion and perfusion MR parameters to assess preoperative short-course radiotherapy response in locally advanced rectal cancer: a comparative explorative study among Standardized Index of Shape by DCE-MRI, intravoxel incoherent motion- and diffusion kurtosis imaging-derived parameters

Complete mesocolic excision and central vascular ligation for right colon cancer: an introduction for abdominal radiologists

Neu im Fachgebiet Radiologie

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Update Radiologie